knowledge -WSS

knowledge

author：fashion 2025-08-22 18:30:34 - browse：8

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Children’s Hospital revives plan for pedestrian bridge

WSS

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Severe heat forecast: Where scorching temperatures will persist over the next week

Color Health wants to make cancer screenings convenient

How a key Senate committee is planning to regulate PBMs

leisure time

knowledge

focus

Jerome Adams on the need for new antivirals for Covid

FDA approves first blood sugar monitor without finger pricks

Moonlake's readout produced a cash windfall. Risks remain

Men with early prostate cancer can safely opt out of treatment

ChatGPT in medicine: STAT answers readers' burning questions

Are embryos people? Reproductive medicine's future depends on the answer

Jerome Adams on the need for new antivirals for Covid

New requirements coming in 2024 for Americans traveling to Europe

Trump demands the U.S. pay no more for drugs than other countries … again

Statins reduce cardiovascular risk in people living with HIV

hotspot

Medicare Advantage isn’t working — for anyone

Ohio train derailment: Experts on toxic chemical risks

Pfizer is about to make a big push in cancer. Will investors listen?

Doctors have an ethical obligation to be advocates

CDC panel: People 65 and older should get a Covid spring booster shot

Using force crossed my mind when examining a defiant young patient

leisure time

entertainment

leisure time

hotspot